Evidence map›Paper›PMID 9549453›Full record

ArticleBMJ (Clinical research ed.)1998

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer.

H J Nielsen, H Pappot, I J Christensen, N Brünner, O Thorlacius-Ussing, F Moesgaard, K Danø, J Grøndahl-Hansen

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2006
    Article
  15. Article
  16. Review
  17. Article
  18. Proteases as prognostic markers in cancer.BMJ (Clinical research ed.) · 1998
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

H J NielsenDepartment of Surgical Gastroenterology, Hvidovre Hospital, Denmark.
H Pappot
I J Christensen
N Brünner
O Thorlacius-Ussing
F Moesgaard
K Danø
J Grøndahl-Hansen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsDenmarkEnzyme-Linked Immunosorbent AssayFollow-Up StudiesHumansNeoplasm ProteinsPlasminogen Activator Inhibitor 1PrognosisProportional Hazards ModelsSurvival AnalysisSurvival RateNeoplasm ProteinsPlasminogen Activator Inhibitor 1

Identifiers

PMID9549453
PMCPMC28485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.